Brief: Interpace Announces Contract With Blue Shield Of California For Thygenext & Thyramir
July 29 (Reuters) - Interpace Diagnostics Group Inc
IDXG.O :
* INTERPACE ANNOUNCES CONTRACT WITH BLUE SHIELD OF
CALIFORNIA FOR
THYGENEXT® & THYRAMIR®
Source text for Eikon: ID:nGNX1phQBc
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million